Business Context and Reporting Period
This Form 8-K is a current report filed by iRhythm Technologies, Inc. (NASDAQ: IRTC) on January 23, 2025. The filing addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and does not contain financial performance data.
Material Changes
The material change disclosed is the departure of a director:
- Mojdeh Poul has notified the Company of her decision not to seek re-election to the Board of Directors at the expiration of her current term.
- Her term ends on the date of the Company's next annual meeting of stockholders.
- The departure is due to her appointment as President and Chief Executive Officer of Integra LifeSciences Holdings Corporation, effective January 6, 2025.
- Ms. Poul confirmed her decision is not based on any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure of the director's departure.
Key Facts for Investor Verification
- Verify the date of the next annual meeting of stockholders to confirm the exact expiration date of Ms. Poul's term.
- Confirm whether the Board has initiated a search for a replacement director.
- Review the Company's proxy statement for the upcoming annual meeting for the final slate of director nominees.